Brasília – Brazil is facing a growing wave of antibiotic-resistant infections, particularly those caused by Gram-negative bacteria, amid weaknesses in diagnostic capacity and national surveillance. Experts warn that insufficient monitoring, fragmented data collection and inconsistent reporting across regions hinder timely responses to outbreaks and make it difficult to guide appropriate antibiotic use.

According to infectious-disease specialists, the main factors driving resistance include the overuse of antibiotics in both human and animal health, long hospital stays in resource-limited facilities and the restricted availability of rapid diagnostic tools to identify resistant pathogens. Without reliable data, hospitals and public-health authorities struggle to select effective treatments or implement containment measures.

At the national level, the lack of integrated surveillance and laboratory networks delays policy action and increases the risk of infections that are difficult or impossible to treat. Experts call for investment in diagnostic infrastructure, standardized data reporting, and coordinated national strategies to strengthen antimicrobial stewardship and safeguard available therapies.

Source: Folha de S.Paulo

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com